CONFIDENTIAL — APPROVED FOR PUBLIC RELEASE · BUREAU FILE COPY RECORDS CURRENT AS OF 29 MAY 2026 · DISTRIBUTION: UNRESTRICTED
VendorInvestigator Independent Testing Bureau · Public Records Division
DOCKET YEAR 2026 · VOL. II
35,156 SAMPLES ON FILE
No fee · No favor
Compound Evidence File
#EC-2026-0850

RAD-140 (Testolone) Raw

Filed under Raw Materials. The bureau holds 114 laboratory returns for this compound from 33 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.

Cross-Index

Subjects Shipping This Compound

33 SUBJECTS
SubjectGradeSamplesMeanMinMaxFirst seenLast seen
Tianjin Finder Chemical TFCCASE #VI-2026-0693 A 7 10.0 10.0 10.0 14 Nov 2025 16 Apr 2026
Sangon BioCASE #VI-2026-0671 A 4 10.0 9.9 10.0 26 Jan 2026 5 Jun 2026
Hubei JianxiangCASE #VI-2026-0048 A 4 10.0 9.9 10.0 6 Jan 2026 13 Apr 2026
Hybio PharmaceuticalCASE #VI-2026-0065 A 4 10.0 10.0 10.0 17 Mar 2026 20 Jun 2026
Sigma-AldrichCASE #VI-2026-0829 A 4 10.0 9.9 10.0 17 Mar 2026 13 Jun 2026
Shanghai ERP BiotechnologyCASE #VI-2026-0936 A 3 10.0 9.9 10.0 28 May 2026 4 Jul 2026
Shanghai Wibson BiotechnologyCASE #VI-2026-0379 A 3 10.0 10.0 10.0 26 Apr 2026 1 Jul 2026
Chinese Peptide CompanyCASE #VI-2026-0184 A 3 10.0 10.0 10.0 13 Feb 2026 11 Jun 2026
AsymchemCASE #VI-2026-0091 A 3 10.0 10.0 10.0 27 Apr 2026 25 Jul 2026
BachemCASE #VI-2026-0314 A 2 10.0 10.0 10.0 2 Jul 2026 5 Jul 2026
HomopeptideCASE #VI-2026-0760 A 6 9.9 9.9 10.0 25 May 2026 25 May 2026
WuXi TIDESCASE #VI-2026-0335 A 5 9.9 9.9 10.0 26 Nov 2025 17 Jul 2026
GenScript PeptidesCASE #VI-2026-0860 A 4 9.9 9.9 10.0 20 May 2026 1 Aug 2026
PolyPeptide GroupCASE #VI-2026-0143 A 4 9.9 9.9 10.0 17 Feb 2026 13 Jul 2026
SinoPepCASE #VI-2026-0387 A 4 9.9 9.9 10.0 9 Feb 2026 10 Aug 2026
AmbioPharmCASE #VI-2026-0177 A 4 9.9 9.9 10.0 2 Dec 2025 28 Jun 2026
Kerui PeptidesCASE #VI-2026-0626 A 3 9.9 9.9 10.0 12 Apr 2026 7 Jul 2026
QYAOBIOCASE #VI-2026-0861 A 2 9.9 9.9 10.0 21 Jan 2026 10 May 2026
JEEP PeptidesCASE #VI-2026-0457 A 2 9.9 9.9 9.9 22 Feb 2026 4 Jul 2026
Mokemei BiotechnologyCASE #VI-2026-0540 A 2 9.9 9.9 10.0 15 Mar 2026 21 May 2026
Flourishglobal PeptideCASE #VI-2026-0630 A 2 9.9 9.9 10.0 4 Jan 2026 7 Jul 2026
Shanghai Sigma AudleyCASE #VI-2026-0505 A 2 9.9 9.9 10.0 6 Jun 2026 14 Jun 2026
Thermo Fisher ScientificCASE #VI-2026-0142 A 2 9.9 9.9 10.0 26 Apr 2026 1 May 2026
Zztai PeptideCASE #VI-2026-0192 X 1 9.6 9.6 9.6 2 Apr 2025 2 Apr 2025
Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 A 5 8.7 6.4 9.8 25 May 2026 25 May 2026
Qingdao Sigma Chemical QSCCASE #VI-2026-0538 A 8 8.5 7.4 10.0 24 May 2026 24 May 2026
Glbiochem (Shanghai)CASE #VI-2026-0704 A 8 8.1 7.1 9.5 24 May 2026 24 May 2026
Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 A 2 7.9 7.9 7.9 24 May 2026 24 May 2026
Shanghai Sigma Audley SSACASE #VI-2026-0486 A 4 7.6 6.9 8.1 21 May 2026 21 May 2026
Simple PeptideCASE #VI-2026-0782 X 2 6.5 4.6 8.4 8 Jul 2025 26 Jan 2026
Shenzhen Loga Tech LG LOGACASE #VI-2026-0920 X 2 5.9 4.6 7.3 20 Jun 2025 19 Jan 2026
Peptides For SaleCASE #VI-2026-0614 X 2 2.5 2.5 2.6 24 Apr 2025 21 May 2026
Guangzhou Lengiuanhuang CosmeticsCASE #VI-2026-0228 X 1 2.4 2.4 2.4 2 Jul 2025 2 Jul 2025

Open any subject to view the batch-level evidence for RAD-140 (Testolone) Raw alone.